- 01

AbbVie GmbH
ABBVNYSEUnited States
$504.4B
+3.2% 1W·+24.3% 1Y
- 02

F. Hoffmann-La Roche AG
ROGSIXSwitzerland
$371.7B
-9.5% 1W·— 1Y
- 03

Novo Nordisk AG
NVONYSEDenmark
$170.0B
— 1W·-24.5% 1Y
- 04

Vertex Pharmaceuticals Inc.
VRTXNASDAQUnited States
$126.6B
-2.0% 1W·+19.9% 1Y
- 05

Bristol-Myers Squibb Gesellschaft (BMS)
BMYNYSEUnited States
$122.0B
+1.1% 1W·+37.0% 1Y
- 06

WuXi AppTec GmbH
02359HKEXChina
$75.9B
-5.7% 1W·+93.5% 1Y
- 07
Lonza Gruppe AG
LONNSIXSwitzerland
$51.2B
+5.6% 1W·+5.0% 1Y
- 08
Bayer AG
BAYNXETRAGermany
$49.1B
+1.6% 1W·+59.8% 1Y
- 09

Jiangsu Hengrui Pharmaceuticals
600276SSEChina
$46.4B
-0.5% 1W·-23.6% 1Y
- 10

Ipsen S.A.
IPNEuronextFrance
$13.8B
+4.4% 1W·+25.6% 1Y
- 11

China National Biotec Group
600161SSEChina
$3.7B
-3.0% 1W·— 1Y
- 12

Sarepta Therapeutics Inc.
SRPTNASDAQUnited States
$1.8B
-4.2% 1W·-24.0% 1Y
- 13

Vetoquinol
VETOEuronextFrance
$1.0B
+0.9% 1W·-4.2% 1Y
Zeige 1–13 von 13
